Despite Challenges, Treatment Advances for SCLC

Headline graphic

This March, LUNGevity Foundation partnered with CURE for their ”Speaking Out” video series, featuring Amy Moore, PhD, vice president of global engagement and patient partnerships at LUNGevity Foundation. This interview with Dr. Moore delves into recent breakthroughs in the treatment of small cell lung cancer (SCLC). Dr. Moore discusses significant advances highlighted in clinical trials, such as the IMpower133 and CASPIAN studies, demonstrating the efficacy of combining immunotherapy with chemotherapy in improving survival rates for patients with extensive-stage SCLC.  

Visit our partners at CURE to watch the full video and gain insights into the progress and challenges in SCLC treatment.

Screenshot of video